36 min listen
Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations
Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations
ratings:
Length:
38 minutes
Released:
Mar 26, 2024
Format:
Podcast episode
Description
Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients? Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000409?ecd=bdc_podcast_libsyn_mscpedu
Released:
Mar 26, 2024
Format:
Podcast episode
Titles in the series (100)
Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations: Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)? Credit available for this activity expires: 5/1/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME